RANI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Rani Therapeutics Holdings Inc (RANI) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive catalysts, has weak financial performance, and shows no strong technical or trading signals to justify an immediate purchase.
The stock's MACD is positive but contracting, RSI is neutral at 49.98, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its pivot level (1.331), with no clear breakout or strong momentum. The short-term trend suggests a 60% chance of a decline in the next day (-1.97%) and week (-0.78%).
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
declining significantly YoY. No recent congress trading data or analyst upgrades.
In Q3 2025, revenue remained at $0, net income dropped by -20.21% YoY to -$5.41M, and EPS fell by -50% YoY to -0.12. Gross margin is 100%, but this is irrelevant given no revenue generation.
No recent analyst ratings or price target changes available.
